Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Licenses Resolver System to German Proteomics Firm

NEW YORK, Aug. 23 – Rosetta Inpharmatics has licensed its Resolver gene expression data analyzer to functional genomics company Europroteome, Rosetta said on Thursday.

Europroteome, based in Hennigsdorf, Germany, will use the system to help it manage and analyze genomic data for its research in epithelial cancers.

Terms of the agreement were not disclosed.

Earlier this month, Rosetta and Agilent Technologies, which exclusively distributes the Resolver system, said that Germany’s Max Planck Institutes for Molecular Genetics, Infection Biology, and Molecular Plant Physiology would act as European demonstration sites for the Resolver system and for Agilent’s DNA Microarray Scanner.  

Rosetta, based in Kirkland, Wash., also said it has launched a satellite customer service operation in Europe, housed at Agilent Technologies' facility in Amsterdam.  

Bill Buffington, vice president and general manager of Agilent Technologies' life sciences division, said at the time that the deal with the research institutes would “allow greater access to the Rosetta Resolver system and Agilent's new open-systems-based DNA Microarray Scanner for prospective users in Europe.”

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.